The challenges facing our health & care system are considerable: the ageing population, an increasing number of chronic diseases, better-informed patients and breakthrough technology continue to push up the demand for but also the cost of health care. This trend offers significant investment opportunities into pioneering biotechnology companies, innovative medical technology providers or leading businesses in the health care services space.
Our Health & Care platform is familiar with the entire lifecycle business, from start-up to public company, and invests across the full value chain. Our multidisciplinary international team is reinforced by a strong international network, including experts from the health and pharma industry.
Health & Care Services
Life Sciences Advisory Board
The Gimv Life Sciences Advisory Board consists of 6 seasoned industry veterans with expertise in drug- and medtech development, company building and M&A. They will assist the Gimv Life Sciences team with portfolio development, deal sourcing and assessing general industry trends.
- Biotech comprising drugs, platform technologies, vaccines and diagnostic tests.
- Medtech such as medical devices, consumables, IT and small equipment.
- Health & Care Services, such as clinics, homecare, integrated elderly care,… but also specialized suppliers to the Health & Care sector.
- Get to know our 5 pillars for value creation
- Look into our portfolio
- Our investment approach and added value
Download the Health & Care platform profile.